NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review

GlobalData
52 Pages - GLDATA63530
$125.00

NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches. MAS platform combines three product categories, namely, MaXcess retractors, its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company’s products find application in spine fusion surgery, including biologics used to aid in the spinal fusion process. NuVasive is headquartered in San Diego, California, the US.

NuVasive Inc Key Recent Developments

Jun 11,2018: NuVasive Announces New Finance Team
May 23,2018: NuVasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients
May 16,2018: NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations
May 01,2018: Nuvasive Announces First Quarter 2018 Financial Results
Apr 24,2018: NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
NuVasive Inc - Key Facts 6
NuVasive Inc - Key Employees 7
NuVasive Inc - Key Employee Biographies 8
NuVasive Inc - Major Products and Services 9
NuVasive Inc - History 10
NuVasive Inc - Company Statement 13
NuVasive Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 17
Company Overview 17
NuVasive Inc - Business Description 18
Product Category: Spinal Hardware 18
Overview 18
Performance 18
Product Category: Surgical Support 18
Overview 18
Performance 18
Geographical Segment: International (excludes Puerto Rico) 18
Performance 18
Geographical Segment: The US 19
Performance 19
R&D Overview 19
NuVasive Inc - Corporate Strategy 20
NuVasive Inc - SWOT Analysis 21
SWOT Analysis - Overview 21
NuVasive Inc - Strengths 21
NuVasive Inc - Weaknesses 23
NuVasive Inc - Opportunities 24
NuVasive Inc - Threats 25
NuVasive Inc - Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios - Capital Market Ratios 27
Financial Ratios - Annual Ratios 28
Performance Chart 31
Financial Performance 31
Financial Ratios - Interim Ratios 32
Financial Ratios - Ratio Charts 33
Section 4 – Company’s Lifesciences Financial Deals and Alliances 34
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
NuVasive Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 35
NuVasive Inc, Recent Deals Summary 36
Section 5 – Company’s Recent Developments 37
Jun 11, 2018: NuVasive Announces New Finance Team 37
May 23, 2018: NuVasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients 38
May 16, 2018: NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations 39
May 01, 2018: Nuvasive Announces First Quarter 2018 Financial Results 40
Apr 24, 2018: NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations 41
Apr 02, 2018: NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches 42
Mar 29, 2018: Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction 43
Feb 26, 2018: NuVasive Announces Fourth Quarter and Full Year 2017 Financial Results 44
Feb 20, 2018: NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services 46
Feb 08, 2018: John DeFord To Join NuVasive Board Of Directors 47
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
NuVasive Inc, Key Facts 6
NuVasive Inc, Key Employees 7
NuVasive Inc, Key Employee Biographies 8
NuVasive Inc, Major Products and Services 9
NuVasive Inc, History 10
NuVasive Inc, Other Locations 15
NuVasive Inc, Subsidiaries 15
NuVasive Inc, Key Competitors 26
NuVasive Inc, Ratios based on current share price 27
NuVasive Inc, Annual Ratios 28
NuVasive Inc, Annual Ratios (Cont...1) 29
NuVasive Inc, Annual Ratios (Cont...2) 30
NuVasive Inc, Interim Ratios 32
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
NuVasive Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 35
NuVasive Inc, Recent Deals Summary 36
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51

List of Figures
NuVasive Inc, Performance Chart (2013 - 2017) 31
NuVasive Inc, Ratio Charts 33
NuVasive Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
NuVasive Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 35

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838